Cencora deepens customer engagement
Cencora remains committed to ensuring life-saving therapies are delivered efficiently and reliably to those who need them most.
Cencora remains committed to ensuring life-saving therapies are delivered efficiently and reliably to those who need them most.
The collaboration combines Dr. Reddy’s and Alvotech’s proven capabilities in biosimilars, thus, speeding up the development process and extending the global reach for this biosimilar candidate.
EmpiRx Health's new Clinical Review Messaging solution makes it effortless for members to stay informed about their medication reviews.
The findings underscore these agreements' vital role in expanding patient access and driving down healthcare costs.
MacroHealth expands its marketplace offerings with acquisition of Foundational Pharmacy Strategies.
Olmesartan medoxomil tablets, USP are indicated for the treatment of hypertension in adults and children six years of age and older, to lower blood pressure.
DIANA honors manufacturers for creating innovative products and promotions for healthcare distribution and improving business practices with distributor partners.
Presented annually since 1956, the Nexus Award is the healthcare distribution industry’s highest individual achievement.
Caregivers can now manage medications for their loved ones, while Medicare customers can access PillPack from Amazon Pharmacy’s pre-sorted and labeled packets.
New collaboration integrates low-cost cash pay options into Scripta’s Rx Navigation platform.
GLP-1 medications have emerged as a breakthrough treatment, with prescriptions growing 38 percent annually between 2022 and 2024 and sales expected to reach $100 billion by 2030.
The latest round of closures follows the shuttering of 900 CVS stores between 2022 and 2024.
The lawsuits argue that the law, scheduled to take effect in 2026, is unconstitutional under multiple provisions.
New research from Shoppers Drug Mart's charitable arm reveals sizeable gaps in education, awareness for common menstrual health conditions.
KeySource announces changes to leadership team.
In pivotal Phase 3 trials, TRYPTYR demonstrated rapid natural tear production as early as Day 1